# Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement

> **NCT03440268** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 154 (estimated)

## Conditions studied

- Surgery--Complications
- Cardiac Valve Disease
- Acute Kidney Injury
- Oxygen Radical Damage
- Post-Op Complication

## Interventions

- **DRUG:** N Acetyl Cysteine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03440268
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-15
- **Primary completion:** 2019-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2018-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03440268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03440268, "Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03440268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*